AI drug discovery
Isomorphic Secures $2.1 Billion for AI-Powered Drug Discovery Expansion
Isomorphic has raised $2.1 billion to enhance its AI-driven drug discovery efforts, backed by Google, marking a significant development in healthcare.
Isomorphic Secures $2.1 Billion to Accelerate AI Drug Discovery Efforts
Isomorphic, supported by Google, raises $2.1 billion to advance AI in drug discovery, promising to transform the pharmaceutical landscape.
Eli Lilly Partners with InSilico for $2.75 Billion AI Drug Discovery Initiative
Eli Lilly has entered a $2.75 billion partnership with InSilico Medicine to enhance AI-driven drug discovery, promising rapid advancements in pharmaceuticals.
Eli Lilly Partners with InSilico for Revolutionary AI Drug Discovery
Eli Lilly has signed a $2.75 billion partnership with InSilico Medicine to enhance drug discovery through AI technology, marking a significant industry milestone.
Eli Lilly Partners with InSilico for Revolutionary AI Drug Discovery
Eli Lilly has partnered with InSilico Medicine for a $2.75 billion AI drug discovery deal, promising to innovate pharmaceutical development.